CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Market dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: PERIPHERAL ARTERY DISEASE MARKET, BY PRODUCT TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Devices
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.2.4. Devices Peripheral Artery Disease Market by Devices type
4.3. Drugs
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.3.4. Drugs Peripheral Artery Disease Market by Drug Type
CHAPTER 5: PERIPHERAL ARTERY DISEASE MARKET, BY END USER
5.1. Overview
5.1.1. Market size and forecast
5.2. Hospitals
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Specialty Clinics
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
CHAPTER 6: PERIPHERAL ARTERY DISEASE MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast By Region
6.2. North America
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by Product Type
6.2.3. Market size and forecast, by End User
6.2.4. Market size and forecast, by country
6.2.4.1. U.S.
6.2.4.1.1. Market size and forecast, by Product Type
6.2.4.1.2. Market size and forecast, by End User
6.2.4.2. Canada
6.2.4.2.1. Market size and forecast, by Product Type
6.2.4.2.2. Market size and forecast, by End User
6.2.4.3. Mexico
6.2.4.3.1. Market size and forecast, by Product Type
6.2.4.3.2. Market size and forecast, by End User
6.3. Europe
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by Product Type
6.3.3. Market size and forecast, by End User
6.3.4. Market size and forecast, by country
6.3.4.1. Germany
6.3.4.1.1. Market size and forecast, by Product Type
6.3.4.1.2. Market size and forecast, by End User
6.3.4.2. France
6.3.4.2.1. Market size and forecast, by Product Type
6.3.4.2.2. Market size and forecast, by End User
6.3.4.3. UK
6.3.4.3.1. Market size and forecast, by Product Type
6.3.4.3.2. Market size and forecast, by End User
6.3.4.4. Italy
6.3.4.4.1. Market size and forecast, by Product Type
6.3.4.4.2. Market size and forecast, by End User
6.3.4.5. Spain
6.3.4.5.1. Market size and forecast, by Product Type
6.3.4.5.2. Market size and forecast, by End User
6.3.4.6. Rest of Europe
6.3.4.6.1. Market size and forecast, by Product Type
6.3.4.6.2. Market size and forecast, by End User
6.4. Asia-Pacific
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by Product Type
6.4.3. Market size and forecast, by End User
6.4.4. Market size and forecast, by country
6.4.4.1. Japan
6.4.4.1.1. Market size and forecast, by Product Type
6.4.4.1.2. Market size and forecast, by End User
6.4.4.2. China
6.4.4.2.1. Market size and forecast, by Product Type
6.4.4.2.2. Market size and forecast, by End User
6.4.4.3. Australia
6.4.4.3.1. Market size and forecast, by Product Type
6.4.4.3.2. Market size and forecast, by End User
6.4.4.4. India
6.4.4.4.1. Market size and forecast, by Product Type
6.4.4.4.2. Market size and forecast, by End User
6.4.4.5. South Korea
6.4.4.5.1. Market size and forecast, by Product Type
6.4.4.5.2. Market size and forecast, by End User
6.4.4.6. Rest of Asia-Pacific
6.4.4.6.1. Market size and forecast, by Product Type
6.4.4.6.2. Market size and forecast, by End User
6.5. LAMEA
6.5.1. Key market trends, growth factors and opportunities
6.5.2. Market size and forecast, by Product Type
6.5.3. Market size and forecast, by End User
6.5.4. Market size and forecast, by country
6.5.4.1. Brazil
6.5.4.1.1. Market size and forecast, by Product Type
6.5.4.1.2. Market size and forecast, by End User
6.5.4.2. Saudi Arabia
6.5.4.2.1. Market size and forecast, by Product Type
6.5.4.2.2. Market size and forecast, by End User
6.5.4.3. South Africa
6.5.4.3.1. Market size and forecast, by Product Type
6.5.4.3.2. Market size and forecast, by End User
6.5.4.4. Rest of LAMEA
6.5.4.4.1. Market size and forecast, by Product Type
6.5.4.4.2. Market size and forecast, by End User
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Top winning strategies
7.3. Product mapping of top 10 player
7.4. Competitive dashboard
7.5. Competitive heatmap
7.6. Top player positioning, 2023
CHAPTER 8: COMPANY PROFILES
8.1. Koninklijke Philips N.V.
8.1.1. Company overview
8.1.2. Key executives
8.1.3. Company snapshot
8.1.4. Operating business segments
8.1.5. Product portfolio
8.1.6. Business performance
8.1.7. Key strategic moves and developments
8.2. B. Braun Melsungen AG
8.2.1. Company overview
8.2.2. Key executives
8.2.3. Company snapshot
8.2.4. Operating business segments
8.2.5. Product portfolio
8.2.6. Business performance
8.2.7. Key strategic moves and developments
8.3. Medtronic
8.3.1. Company overview
8.3.2. Key executives
8.3.3. Company snapshot
8.3.4. Operating business segments
8.3.5. Product portfolio
8.3.6. Business performance
8.3.7. Key strategic moves and developments
8.4. Bayer AG
8.4.1. Company overview
8.4.2. Key executives
8.4.3. Company snapshot
8.4.4. Operating business segments
8.4.5. Product portfolio
8.4.6. Business performance
8.4.7. Key strategic moves and developments
8.5. Boston Scientific Corporation
8.5.1. Company overview
8.5.2. Key executives
8.5.3. Company snapshot
8.5.4. Operating business segments
8.5.5. Product portfolio
8.5.6. Business performance
8.5.7. Key strategic moves and developments
8.6. Becton Dickinson and Company
8.6.1. Company overview
8.6.2. Key executives
8.6.3. Company snapshot
8.6.4. Operating business segments
8.6.5. Product portfolio
8.6.6. Business performance
8.6.7. Key strategic moves and developments
8.7. Terumo Medical Corporation
8.7.1. Company overview
8.7.2. Key executives
8.7.3. Company snapshot
8.7.4. Operating business segments
8.7.5. Product portfolio
8.7.6. Business performance
8.7.7. Key strategic moves and developments
8.8. Biotronik SE & Co. KG
8.8.1. Company overview
8.8.2. Key executives
8.8.3. Company snapshot
8.8.4. Operating business segments
8.8.5. Product portfolio
8.8.6. Business performance
8.8.7. Key strategic moves and developments
8.9. Cardinal Health
8.9.1. Company overview
8.9.2. Key executives
8.9.3. Company snapshot
8.9.4. Operating business segments
8.9.5. Product portfolio
8.9.6. Business performance
8.9.7. Key strategic moves and developments
8.10. Abbott Laboratories
8.10.1. Company overview
8.10.2. Key executives
8.10.3. Company snapshot
8.10.4. Operating business segments
8.10.5. Product portfolio
8.10.6. Business performance
8.10.7. Key strategic moves and developments
List of Tables
Table 01. Global Peripheral Artery Disease Market, by Product Type, 2023-2035 ($Million)
Table 02. Peripheral Artery Disease Market for Devices, by Region, 2023-2035 ($Million)
Table 03. Global Devices Peripheral Artery Disease Market, by Devices Type, 2023-2035 ($Million)
Table 04. Peripheral Artery Disease Market for Drugs, by Region, 2023-2035 ($Million)
Table 05. Global Drugs Peripheral Artery Disease Market, by Drug Type, 2023-2035 ($Million)
Table 06. Global Peripheral Artery Disease Market, by End-user, 2023-2035 ($Million)
Table 07. Peripheral Artery Disease Market for Hospitals, by Region, 2023-2035 ($Million)
Table 08. Peripheral Artery Disease Market for Specialty Clinics, by Region, 2023-2035 ($Million)
Table 09. Peripheral Artery Disease Market, by Region, 2023-2035 ($Million)
Table 10. North America Peripheral Artery Disease Market, by Product Type, 2023-2035 ($Million)
Table 11. North America Peripheral Artery Disease Market, by End-user, 2023-2035 ($Million)
Table 12. North America Peripheral Artery Disease Market, by Country, 2023-2035 ($Million)
Table 13. U.S. Peripheral Artery Disease Market, by Product Type, 2023-2035 ($Million)
Table 14. U.S. Peripheral Artery Disease Market, by End-user, 2023-2035 ($Million)
Table 15. Canada Peripheral Artery Disease Market, by Product Type, 2023-2035 ($Million)
Table 16. Canada Peripheral Artery Disease Market, by End-user, 2023-2035 ($Million)
Table 17. Mexico Peripheral Artery Disease Market, by Product Type, 2023-2035 ($Million)
Table 18. Mexico Peripheral Artery Disease Market, by End-user, 2023-2035 ($Million)
Table 19. Europe Peripheral Artery Disease Market, by Product Type, 2023-2035 ($Million)
Table 20. Europe Peripheral Artery Disease Market, by End-user, 2023-2035 ($Million)
Table 21. Europe Peripheral Artery Disease Market, by Country, 2023-2035 ($Million)
Table 22. Germany Peripheral Artery Disease Market, by Product Type, 2023-2035 ($Million)
Table 23. Germany Peripheral Artery Disease Market, by End-user, 2023-2035 ($Million)
Table 24. France Peripheral Artery Disease Market, by Product Type, 2023-2035 ($Million)
Table 25. France Peripheral Artery Disease Market, by End-user, 2023-2035 ($Million)
Table 26. UK Peripheral Artery Disease Market, by Product Type, 2023-2035 ($Million)
Table 27. UK Peripheral Artery Disease Market, by End-user, 2023-2035 ($Million)
Table 28. Italy Peripheral Artery Disease Market, by Product Type, 2023-2035 ($Million)
Table 29. Italy Peripheral Artery Disease Market, by End-user, 2023-2035 ($Million)
Table 30. Spain Peripheral Artery Disease Market, by Product Type, 2023-2035 ($Million)
Table 31. Spain Peripheral Artery Disease Market, by End-user, 2023-2035 ($Million)
Table 32. Rest of Europe Peripheral Artery Disease Market, by Product Type, 2023-2035 ($Million)
Table 33. Rest of Europe Peripheral Artery Disease Market, by End-user, 2023-2035 ($Million)
Table 34. Asia-Pacific Peripheral Artery Disease Market, by Product Type, 2023-2035 ($Million)
Table 35. Asia-Pacific Peripheral Artery Disease Market, by End-user, 2023-2035 ($Million)
Table 36. Asia-Pacific Peripheral Artery Disease Market, by Country, 2023-2035 ($Million)
Table 37. Japan Peripheral Artery Disease Market, by Product Type, 2023-2035 ($Million)
Table 38. Japan Peripheral Artery Disease Market, by End-user, 2023-2035 ($Million)
Table 39. China Peripheral Artery Disease Market, by Product Type, 2023-2035 ($Million)
Table 40. China Peripheral Artery Disease Market, by End-user, 2023-2035 ($Million)
Table 41. Australia Peripheral Artery Disease Market, by Product Type, 2023-2035 ($Million)
Table 42. Australia Peripheral Artery Disease Market, by End-user, 2023-2035 ($Million)
Table 43. India Peripheral Artery Disease Market, by Product Type, 2023-2035 ($Million)
Table 44. India Peripheral Artery Disease Market, by End-user, 2023-2035 ($Million)
Table 45. South Korea Peripheral Artery Disease Market, by Product Type, 2023-2035 ($Million)
Table 46. South Korea Peripheral Artery Disease Market, by End-user, 2023-2035 ($Million)
Table 47. Rest of Asia-Pacific Peripheral Artery Disease Market, by Product Type, 2023-2035 ($Million)
Table 48. Rest of Asia-Pacific Peripheral Artery Disease Market, by End-user, 2023-2035 ($Million)
Table 49. LAMEA Peripheral Artery Disease Market, by Product Type, 2023-2035 ($Million)
Table 50. LAMEA Peripheral Artery Disease Market, by End-user, 2023-2035 ($Million)
Table 51. LAMEA Peripheral Artery Disease Market, by Country, 2023-2035 ($Million)
Table 52. Brazil Peripheral Artery Disease Market, by Product Type, 2023-2035 ($Million)
Table 53. Brazil Peripheral Artery Disease Market, by End-user, 2023-2035 ($Million)
Table 54. Saudi Arabia Peripheral Artery Disease Market, by Product Type, 2023-2035 ($Million)
Table 55. Saudi Arabia Peripheral Artery Disease Market, by End-user, 2023-2035 ($Million)
Table 56. South Africa Peripheral Artery Disease Market, by Product Type, 2023-2035 ($Million)
Table 57. South Africa Peripheral Artery Disease Market, by End-user, 2023-2035 ($Million)
Table 58. Rest of LAMEA Peripheral Artery Disease Market, by Product Type, 2023-2035 ($Million)
Table 59. Rest of LAMEA Peripheral Artery Disease Market, by End-user, 2023-2035 ($Million)
Table 60. Koninklijke Philips N.V.: Key Executives
Table 61. Koninklijke Philips N.V.: Company Snapshot
Table 62. Koninklijke Philips N.V.: Product Segments
Table 63. Koninklijke Philips N.V.: Service Segments
Table 64. Koninklijke Philips N.V.: Product Portfolio
Table 65. Koninklijke Philips N.V.: Key Strategies
Table 66. B. Braun Melsungen AG: Key Executives
Table 67. B. Braun Melsungen AG: Company Snapshot
Table 68. B. Braun Melsungen AG: Product Segments
Table 69. B. Braun Melsungen AG: Service Segments
Table 70. B. Braun Melsungen AG: Product Portfolio
Table 71. B. Braun Melsungen AG: Key Strategies
Table 72. Medtronic: Key Executives
Table 73. Medtronic: Company Snapshot
Table 74. Medtronic: Product Segments
Table 75. Medtronic: Service Segments
Table 76. Medtronic: Product Portfolio
Table 77. Medtronic: Key Strategies
Table 78. Bayer AG: Key Executives
Table 79. Bayer AG: Company Snapshot
Table 80. Bayer AG: Product Segments
Table 81. Bayer AG: Service Segments
Table 82. Bayer AG: Product Portfolio
Table 83. Bayer AG: Key Strategies
Table 84. Boston Scientific Corporation: Key Executives
Table 85. Boston Scientific Corporation: Company Snapshot
Table 86. Boston Scientific Corporation: Product Segments
Table 87. Boston Scientific Corporation: Service Segments
Table 88. Boston Scientific Corporation: Product Portfolio
Table 89. Boston Scientific Corporation: Key Strategies
Table 90. Becton Dickinson and Company: Key Executives
Table 91. Becton Dickinson and Company: Company Snapshot
Table 92. Becton Dickinson and Company: Product Segments
Table 93. Becton Dickinson and Company: Service Segments
Table 94. Becton Dickinson and Company: Product Portfolio
Table 95. Becton Dickinson and Company: Key Strategies
Table 96. Terumo Medical Corporation: Key Executives
Table 97. Terumo Medical Corporation: Company Snapshot
Table 98. Terumo Medical Corporation: Product Segments
Table 99. Terumo Medical Corporation: Service Segments
Table 100. Terumo Medical Corporation: Product Portfolio
Table 101. Terumo Medical Corporation: Key Strategies
Table 102. Biotronik SE & Co. KG: Key Executives
Table 103. Biotronik SE & Co. KG: Company Snapshot
Table 104. Biotronik SE & Co. KG: Product Segments
Table 105. Biotronik SE & Co. KG: Service Segments
Table 106. Biotronik SE & Co. KG: Product Portfolio
Table 107. Biotronik SE & Co. KG: Key Strategies
Table 108. Cardinal Health: Key Executives
Table 109. Cardinal Health: Company Snapshot
Table 110. Cardinal Health: Product Segments
Table 111. Cardinal Health: Service Segments
Table 112. Cardinal Health: Product Portfolio
Table 113. Cardinal Health: Key Strategies
Table 114. Abbott Laboratories: Key Executives
Table 115. Abbott Laboratories: Company Snapshot
Table 116. Abbott Laboratories: Product Segments
Table 117. Abbott Laboratories: Service Segments
Table 118. Abbott Laboratories: Product Portfolio
Table 119. Abbott Laboratories: Key Strategies
List of Figures
Figure 01. Peripheral Artery Disease Market, 2023-2035
Figure 02. Segmentation of Peripheral Artery Disease Market,2023-2035
Figure 03. Top Impacting Factors in Peripheral Artery Disease Market
Figure 04. Top Investment Pockets in Peripheral Artery Disease Market (2024-2035)
Figure 05. Bargaining Power of Suppliers
Figure 06. Bargaining Power of Buyers
Figure 07. Threat of Substitution
Figure 08. Threat of Substitution
Figure 09. Competitive Rivalry
Figure 10. Global Peripheral Artery Disease Market:Drivers, Restraints and Opportunities
Figure 11. Peripheral Artery Disease Market, by Product Type, 2023 and 2035(%)
Figure 12. Comparative Share Analysis of Peripheral Artery Disease Market for Devices, by Country 2023 and 2035(%)
Figure 13. Comparative Share Analysis of Peripheral Artery Disease Market for Drugs, by Country 2023 and 2035(%)
Figure 14. Peripheral Artery Disease Market, by End-user, 2023 and 2035(%)
Figure 15. Comparative Share Analysis of Peripheral Artery Disease Market for Hospitals, by Country 2023 and 2035(%)
Figure 16. Comparative Share Analysis of Peripheral Artery Disease Market for Specialty Clinics, by Country 2023 and 2035(%)
Figure 17. Peripheral Artery Disease Market by Region, 2023 and 2035(%)
Figure 18. U.S. Peripheral Artery Disease Market, 2023-2035 ($Million)
Figure 19. Canada Peripheral Artery Disease Market, 2023-2035 ($Million)
Figure 20. Mexico Peripheral Artery Disease Market, 2023-2035 ($Million)
Figure 21. Germany Peripheral Artery Disease Market, 2023-2035 ($Million)
Figure 22. France Peripheral Artery Disease Market, 2023-2035 ($Million)
Figure 23. UK Peripheral Artery Disease Market, 2023-2035 ($Million)
Figure 24. Italy Peripheral Artery Disease Market, 2023-2035 ($Million)
Figure 25. Spain Peripheral Artery Disease Market, 2023-2035 ($Million)
Figure 26. Rest of Europe Peripheral Artery Disease Market, 2023-2035 ($Million)
Figure 27. Japan Peripheral Artery Disease Market, 2023-2035 ($Million)
Figure 28. China Peripheral Artery Disease Market, 2023-2035 ($Million)
Figure 29. Australia Peripheral Artery Disease Market, 2023-2035 ($Million)
Figure 30. India Peripheral Artery Disease Market, 2023-2035 ($Million)
Figure 31. South Korea Peripheral Artery Disease Market, 2023-2035 ($Million)
Figure 32. Rest of Asia-Pacific Peripheral Artery Disease Market, 2023-2035 ($Million)
Figure 33. Brazil Peripheral Artery Disease Market, 2023-2035 ($Million)
Figure 34. Saudi Arabia Peripheral Artery Disease Market, 2023-2035 ($Million)
Figure 35. South Africa Peripheral Artery Disease Market, 2023-2035 ($Million)
Figure 36. Rest of LAMEA Peripheral Artery Disease Market, 2023-2035 ($Million)
Figure 37. Top Winning Strategies, by Year
Figure 38. Top Winning Strategies, by Development
Figure 39. Top Winning Strategies, by Company
Figure 40. Product Mapping of Top 10 Players
Figure 41. Competitive Dashboard
Figure 42. Competitive Heatmap: Peripheral Artery Disease Market
Figure 43. Top Player Positioning, 2023